{"id":"https://openalex.org/W2007983159","doi":"https://doi.org/10.1016/0009-9236(95)90052-7","title":"Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans","display_name":"Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans","publication_year":1995,"publication_date":"1995-10-01","ids":{"openalex":"https://openalex.org/W2007983159","doi":"https://doi.org/10.1016/0009-9236(95)90052-7","mag":"2007983159","pmid":"https://pubmed.ncbi.nlm.nih.gov/7586931"},"language":"en","primary_location":{"id":"doi:10.1016/0009-9236(95)90052-7","doi":"https://doi.org/10.1016/0009-9236(95)90052-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0009-9236(95)90052-7","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031025442","display_name":"Olav Spigset","orcid":"https://orcid.org/0000-0001-7902-9014","observed_orcids":["https://orcid.org/0000-0001-7902-9014"]},"institutions":[{"id":"https://openalex.org/I4210099621","display_name":"University Hospital of Ume\u00e5","ror":"https://ror.org/012k96e85","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210099621"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Olav Spigset","raw_affiliation_strings":["Division of Clinical Pharmacology, Norrland University Hospital, Ume\u00e5, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Norrland University Hospital, Ume\u00e5, Sweden","institution_ids":["https://openalex.org/I4210099621"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078333640","display_name":"Lena Carleborg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099621","display_name":"University Hospital of Ume\u00e5","ror":"https://ror.org/012k96e85","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210099621"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lena Carleborg","raw_affiliation_strings":["Division of Clinical Pharmacology, Norrland University Hospital, Umea\u030a, Sweden","Division of Clinical Pharmacology, Norrland University Hospital, Ume\u00e5, Sweden,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Norrland University Hospital, Umea\u030a, Sweden","institution_ids":["https://openalex.org/I4210099621"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Norrland University Hospital, Ume\u00e5, Sweden,","institution_ids":["https://openalex.org/I4210099621"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000303989","display_name":"Karin Hedenmalm","orcid":"https://orcid.org/0000-0002-9544-9163","observed_orcids":["https://orcid.org/0000-0002-9544-9163"]},"institutions":[{"id":"https://openalex.org/I4210099621","display_name":"University Hospital of Ume\u00e5","ror":"https://ror.org/012k96e85","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210099621"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Karin Hedenmalm","raw_affiliation_strings":["Division of Clinical Pharmacology, Norrland University Hospital, Umea\u030a, Sweden","Division of Clinical Pharmacology, Norrland University Hospital, Ume\u00e5, Sweden,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Norrland University Hospital, Umea\u030a, Sweden","institution_ids":["https://openalex.org/I4210099621"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Norrland University Hospital, Ume\u00e5, Sweden,","institution_ids":["https://openalex.org/I4210099621"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104363172","display_name":"Rune Dahlqvist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099621","display_name":"University Hospital of Ume\u00e5","ror":"https://ror.org/012k96e85","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210099621"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Rune Dahlqvist","raw_affiliation_strings":["Division of Clinical Pharmacology, Norrland University Hospital, Umea\u030a, Sweden","Division of Clinical Pharmacology, Norrland University Hospital, Ume\u00e5, Sweden,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Norrland University Hospital, Umea\u030a, Sweden","institution_ids":["https://openalex.org/I4210099621"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Norrland University Hospital, Ume\u00e5, Sweden,","institution_ids":["https://openalex.org/I4210099621"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031025442"],"corresponding_institution_ids":["https://openalex.org/I4210099621"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":4.7854,"has_fulltext":false,"cited_by_count":94,"citation_normalized_percentile":{"value":0.95590829,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"58","issue":"4","first_page":"399","last_page":"403"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9480000138282776},{"id":"https://openalex.org/keywords/cigarette-smoking","display_name":"cigarette smoking","score":0.996999979019165},{"id":"https://openalex.org/keywords/cyp1a2","display_name":"CYP1A2","score":0.8980000019073486},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.7129999995231628},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9779999852180481},{"id":"https://openalex.org/keywords/smokers-versus-nonsmokers","display_name":"smokers versus non-smokers","score":0.8579999804496765},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.6669999957084656},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.8399999737739563},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.9719243049621582},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8054687976837158},{"id":"https://openalex.org/C86745063","wikidata":"https://www.wikidata.org/wiki/Q3737406","display_name":"CYP1A2","level":4,"score":0.7887569069862366},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5902435183525085},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5788527727127075},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.48616406321525574},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44752347469329834},{"id":"https://openalex.org/C3019361228","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral dose","level":3,"score":0.4362197518348694},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37137371301651},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34739744663238525},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.1384115219116211},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.10924971103668213},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.07146185636520386},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.054188698530197144}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010088","descriptor_name":"Oxidoreductases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010088","descriptor_name":"Oxidoreductases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012907","descriptor_name":"Smoking","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019388","descriptor_name":"Cytochrome P-450 CYP1A2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0009-9236(95)90052-7","doi":"https://doi.org/10.1016/0009-9236(95)90052-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0009-9236(95)90052-7","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:7586931","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7586931","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W60886506","https://openalex.org/W1969652902","https://openalex.org/W1980165182","https://openalex.org/W1981628559","https://openalex.org/W1984318995","https://openalex.org/W1987889187","https://openalex.org/W1992271063","https://openalex.org/W1997364324","https://openalex.org/W2010258076","https://openalex.org/W2023163409","https://openalex.org/W2036548290","https://openalex.org/W2039613541","https://openalex.org/W2046615707","https://openalex.org/W2054377010","https://openalex.org/W2078593475","https://openalex.org/W2080496807","https://openalex.org/W2081395866","https://openalex.org/W2090315557","https://openalex.org/W2105876917","https://openalex.org/W2114903378","https://openalex.org/W2345949320","https://openalex.org/W2403593617","https://openalex.org/W2422739508","https://openalex.org/W2461565216"],"related_works":["https://openalex.org/W2090628258","https://openalex.org/W2060473370","https://openalex.org/W2084743004","https://openalex.org/W2094555978","https://openalex.org/W2023580320","https://openalex.org/W1995862457","https://openalex.org/W2046107045","https://openalex.org/W4404506358","https://openalex.org/W1563602211","https://openalex.org/W2070644309"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Although":[1],"fluvoxamine":[2,30,48,58,78,189,210],"inhibits":[3],"the":[4,22,27,35,45,100,111],"biotransformation":[5],"of":[6,24,29,37,47,57,71,75,188,197,207],"drugs":[7,38],"known":[8],"to":[9,21,79],"be":[10],"metabolized":[11],"by":[12,40,61],"CYP1A2,":[13,41],"there":[14],"are":[15],"no":[16],"data":[17],"available":[18],"with":[19,203],"regard":[20],"importance":[23],"CYP1A2":[25,208],"for":[26,65],"metabolism":[28,36],"itself.":[31],"Because":[32],"smoking":[33],"induces":[34],"catalyzed":[39],"this":[42],"study":[43],"investigated":[44],"pharmacokinetics":[46],"in":[49,209],"smokers":[50,81,94,149,168],"and":[51,89,104,127,150,155,173],"nonsmokers.":[52,91],"METHODS:":[53],"The":[54,93,140,161],"serum":[55,101,108,186],"concentration":[56],"was":[59,164],"determined":[60],"high-performance":[62],"liquid":[63],"chromatography":[64],"48":[66],"hours":[67],"after":[68,192],"oral":[69,162,195],"administration":[70],"a":[72,193,204],"single":[73,194],"dose":[74,196],"50":[76],"mg":[77],"12":[80,90],"(>":[82],"or":[83],"=":[84,125,137],"10":[85],"cigarettes":[86],"per":[87],"day)":[88],"RESULTS:":[92],"had":[95,184],"significantly":[96,105,147],"lower":[97,106,185],"areas":[98],"under":[99],"concentration-time":[102],"curve":[103],"maximal":[107],"concentrations":[109,187],"than":[110,190],"nonsmokers":[112,151,174,191],"(mean":[113],"+/-":[114,117,121,129,133,153,157,170,176],"SD,":[115],"771":[116],"346":[118],"versus":[119,131],"1110":[120],"511":[122],"nmol.hr.L-1":[123],"[p":[124,136],"0.012]":[126],"39.1":[128],"17.3":[130],"57.7":[132],"21.5":[134],"nmol.L-1":[135],"0.012],":[138],"respectively).":[139,160],"terminal":[141],"elimination":[142],"half-life":[143],"did":[144],"not":[145,180],"differ":[146],"between":[148],"(10.1":[152],"1.9":[154,171],"10.7":[156],"2.3":[158],"hours,":[159],"clearance":[163],"high":[165],"among":[166],"both":[167],"(4.1":[169],"L.min-1)":[172],"(3.3":[175],"2.7":[177],"L.min-1;":[178],"difference":[179],"significant).":[181],"CONCLUSION:":[182],"Smokers":[183],"fluvoxamine.":[198],"This":[199],"finding":[200],"is":[201],"consistent":[202],"possible":[205],"role":[206],"metabolism.":[211]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}